YH12852, a potent and highly selective 5‐HT4 receptor agonist, significantly improves both upper and lower gastrointestinal motility in a guinea pig model of postoperative ileus. Issue 10 (18th May 2017)

• Record Type: Journal Article
• Authors: Hussain, Z.; Lee, Y. J.; Yang, H.; Jeong, E. J.; Sim, J. Y.; Park, H.
• Is Part Of: Neurogastroenterology & motility. Volume 29:Issue 10(2017)
• Page Start: 1
• Page End: 6
• Publication Date: 2017-05-18
• Subjects: 5‐HT4 receptor agonist -- GR113808 -- guinea pig -- postoperative ileus -- YH12852; Gastrointestinal system -- Motility -- Periodicals; Gastrointestinal system -- Innervation -- Periodicals; 616.33
• DOI: 10.1111/nmo.13094
• Languages: English
• ISSNs: 1350-1925

Abstract

Abstract: Background: Postoperative ileus (POI) is a transient gastrointestinal (GI) dysmotility that commonly develops after abdominal surgery. YH12852, a novel, potent and highly selective 5‐hydroxytryptamine 4 (5‐HT4 ) receptor agonist, has been shown to improve both upper and lower GI motility in various animal studies and may have applications for the treatment of POI. Here, we investigated the effects and mechanism of action of YH12852 in a guinea pig model of POI to explore its therapeutic potential. Methods: The guinea pig model of POI was created by laparotomy, evisceration, and gentle manipulation of the cecum for 60 seconds, followed by closure with sutures under anesthesia. Group 1 received an oral administration of vehicle or YH12852 (1, 3, 10 or 30 mg/kg) only, while POI Group 2 was intraperitoneally pretreated with vehicle or 5‐HT4 receptor antagonist GR113808 (10 mg/kg) prior to oral dosing of vehicle or YH12852 (3 or 10 mg/kg). Upper GI transit was evaluated by assessing the migration of a charcoal mixture in the small intestine, while lower GI transit was assessed via measurement of fecal pellet output (FPO). Key Results: YH12852 significantly accelerated upper and lower GI transit at the doses of 3, 10, and 30 mg/kg and reached its maximal effect at 10 mg/kg. These effects were significantly blocked by pretreatment of GR113808 10 mg/kg. Conclusion and Inferences: Oral administration of YH12852 significantly accelerates and restores delayed upper and lower GI transit in a guinea pig model of POI. This drug may serve as a useful candidate for the treatment of postoperative ileus. Abstract : YH12852 significantly accelerated upper and lower GI transit in POI model of guinea pig. These effects were significantly blocked by pretreatment of GR113808 10 mg/kg.